✦ LIBER ✦

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo

✍ Scribed by Rosana B. Michel; Philip M. Andrews; Adriane V. Rosario; David M. Goldenberg; M. Jules Mattes

Book ID: 116798851
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 228 KB
Volume: 32
Category: Article
ISSN: 0969-8051
DOI: 10.1016/j.nucmedbio.2005.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Toxicity of chlorambucil and daunorubici

Toxicity of chlorambucil and daunorubicin antibody conjugates for sarcoma cells in vitro

✍ M. Pagé; S. Landry; D. Thibeault; L. Dumas 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Supraagonistic, bispecific single-chain

Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivo

✍ Ludger Grosse-Hovest; Wolfgang Wick; Rosa Minoia; Michael Weller; Hans-Georg Ram 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 202 KB

## Abstract Here we characterize the antitumor activity of a recombinant bispecific single‐chain antibody isolated from the serum of cloned transgenic cows. The antibody, termed r28M, is directed to a melanoma‐associated proteoglycan, also expressed on glioblastoma cells, and to human CD28. Bound t

Evaluation of four CD22 antibodies as ri

Evaluation of four CD22 antibodies as ricin a chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

✍ Guo-Liang Shen; Jia-Ling Li; Maria-Ana Ghetie; Victor Ghetie; Richard D. May; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 668 KB

Ricin A chain-containing immunotoxins (IT-As) specific for the human &ell antigen, CD22, were prepared from 4 monoclonal antibodies (MAbs) or their Fab' fragments: RFB4, HD6, UV22-I and UV22-2. The ITS were tested for their ability to kill cells from the Burkitt lymphoma line, Daudi, the pre-6cell l

Magnetic Nanoparticle−Peptide Conjugates

Magnetic Nanoparticle−Peptide Conjugates for in Vitro and in Vivo Targeting and Extraction of Cancer Cells

✍ Scarberry, Kenneth E.; Dickerson, Erin B.; McDonald, John F.; Zhang, Z. John 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 216 KB

In vivo versus in vitro assays for asses

In vivo versus in vitro assays for assessment of T- and B- cell function

✍ Martin F. Bachmann; Thomas M. Kündig 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 885 KB

As mice deficient in a particular gene provide an increasing number of novel in vivo models, in vivo assays that examine immune function are becoming a central issue. We found that the sensitivities of in vivo and in vitro assays are strikingly different. These differences have important implication